Comparative Visual And Refractive Outcomes At One Month Using Three Johnson & Johnson Iols: Monofocal Sensar Aab00, Tecnis Eyhance, And Tecnis Puresee

To assess one-month postoperative visual acuity and refractive outcomes in patients receiving three different Johnson & Johnson intraocular lens (IOL) models—Monofocal Sensar AAB00, Tecnis Eyhance, and Tecnis Puresee—during routine phacoemulsification cataract surgery. The primary objective was to compare uncorrected distance visual acuity (UCVA) and postoperative spherical-equivalent (SE) refraction. Secondary objectives included evaluating intermediate and near UCVA to determine the extent to which each IOL provided broader functional vision, potentially reducing dependence on spectacles for everyday tasks.

A single surgeon at VISTA Eye Specialist Kajang, Malaysia, performed all surgeries between March and December 2024 using a standardized phacoemulsification protocol. Each IOL shares a hydrophobic acrylic platform with aspheric optics but varies in design to enhance intermediate and near performance.

A retrospective review identified patients who underwent uncomplicated cataract surgery with one of the three Johnson & Johnson IOLs. Data collected included age, preoperative best-corrected visual acuity, and one-month postoperative UCVA (distance, intermediate, near) plus manifest refraction. Spherical-equivalent refractions (mean ± standard deviation) were calculated by combining the sphere and half the cylinder. Intermediate (20/x) and near (N-notation) acuities were categorized to gauge functional vision. Group differences were analyzed using ANOVA (p<0.05 considered significant).

A total of 88 eyes were analyzed. Monofocal Sensar AAB00 (n=59) had a mean final SE of −0.27 ± 0.33 D, with over 80% achieving 6/9 or better distance UCVA. Tecnis Eyhance (n=24) yielded −0.15 ± 0.32 D SE and provided excellent intermediate vision (approximately 80% at 20/25 or better), with near acuities typically N4–N6. Tecnis Puresee (n=5) showed −0.23 ± 0.24 D SE, with 80% achieving 20/25 or better intermediate and N6 near. Puresee’s smaller sample size reflects its recent introduction into Malaysia at the end of September 2024. No significant intergroup differences were detected for distance UCVA or final SE (p>0.05). Mean patient age ranged from 56 to 64 years.

All three Johnson & Johnson IOLs delivered favorable one-month distance outcomes and low variability in final refraction. Tecnis Eyhance and Tecnis Puresee both demonstrated strong functional vision for intermediate and near tasks, suggesting an option for reduced spectacle dependence. Monofocal Sensar AAB00 continued to provide excellent distance acuity. Further prospective studies may clarify subtle performance differences, especially for Puresee as it becomes more widely adopted.